ArticlemAbs2019

Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk.

Nicoletta Bivi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.